Company Filing History:
4 out of 58 
2 out of 488 
1 out of 9 Years Active: 1999-2016
Title: Sylvia Braselmann: Innovator in Polycyclic Alkaloid Synthesis
Introduction
Sylvia Braselmann is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of chemistry, particularly in the synthesis of polycyclic alkaloids. With a total of 6 patents to her name, her work has implications for pharmaceutical applications and disease treatment.
Latest Patents
Her latest patents focus on the synthesis of polycyclic alkaloids. These patents disclose embodiments concerning polycyclic alkaloid compounds and methods for their use and synthesis. Specific embodiments detail polycyclic alkaloids with a fused, six-membered ring, as well as those with a fused, five-membered ring. The methods for creating these polycyclic alkaloids are outlined, along with their potential use as prophylactics or treatments for certain diseases. Additionally, pharmaceutical compositions comprising these polycyclic alkaloids and their applications are also disclosed.
Career Highlights
Throughout her career, Sylvia has worked with notable companies such as Onyx Pharmaceuticals, Inc. and Rigel Pharmaceuticals, Incorporated. Her experience in these organizations has allowed her to develop her expertise in the field of pharmaceutical chemistry.
Collaborations
Some of her notable coworkers include Dane A Goff and Donald G Payan. Their collaborative efforts have contributed to the advancement of research in polycyclic alkaloids.
Conclusion
Sylvia Braselmann's innovative work in the synthesis of polycyclic alkaloids showcases her significant impact on the field of chemistry and pharmaceuticals. Her contributions continue to pave the way for advancements in medical treatments and drug development.